EDTUTC-4 New YorkLog in Sign up

CUE
Cue Biopharma, Inc.
stockNASDAQ

At CloseOct 2, 2026 3:59:42 PM EDT

25.72USD+1.861%(+0.47)157,037

CUE News

Day breaks

05:50 AM EDTB.Riley reiterates Cue Biopharma stock rating on allergy data ·

Investing.com

11:20 AM EDTCue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset ·

Seeking Alpha

11:08 AM EDTCue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria Transcript ·

Seeking Alpha

07:00 AM EDTAt a glance: stocks gapping up premarket ·

Seeking Alpha

06:55 AM EDTCue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results ·

InvestorsHub

04:24 AM EDTWhy is Cue Biopharma stock surging today? ·

Investing.com

06:04 AM EDTCue Biopharma reports positive phase 2 results for CUE-221 ·

Investing.com

06:00 AM EDTCue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria ·

GlobeNewswire Inc.

11:28 AM EDTCue Biopharma is a new Buy at B. Riley on valuation ·

Seeking Alpha

05:01 AM EDTCue Biopharma stock initiated at Buy by B.Riley on allergy drug potential ·

Investing.com